18359663

Source:http://linkedlifedata.com/resource/pubmed/id/18359663

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists.
Subject	Predicate	Object	Context
pubmed-article:18359663	rdf:type	pubmed:Citation	lld:pubmed
pubmed-article:18359663	lifeskim:mentions	umls-concept:C0087111	lld:lifeskim
pubmed-article:18359663	lifeskim:mentions	umls-concept:C0376705	lld:lifeskim
pubmed-article:18359663	lifeskim:mentions	umls-concept:C0001899	lld:lifeskim
pubmed-article:18359663	lifeskim:mentions	umls-concept:C0524909	lld:lifeskim
pubmed-article:18359663	lifeskim:mentions	umls-concept:C0376147	lld:lifeskim
pubmed-article:18359663	lifeskim:mentions	umls-concept:C0796545	lld:lifeskim
pubmed-article:18359663	lifeskim:mentions	umls-concept:C2257651	lld:lifeskim
pubmed-article:18359663	lifeskim:mentions	umls-concept:C0201836	lld:lifeskim
pubmed-article:18359663	pubmed:issue	2	lld:pubmed
pubmed-article:18359663	pubmed:dateCreated	2008-5-30	lld:pubmed
pubmed-article:18359663	pubmed:abstractText	Alanine aminotransferase (ALT) is one of the main indicators for inflammatory activity in chronic hepatitis B. During interferon-based therapy, approximately 25%-40% of patients exhibit an ALT flare.	lld:pubmed
pubmed-article:18359663	pubmed:language	eng	lld:pubmed
pubmed-article:18359663	pubmed:journal	http://linkedlifedata.com/r...	lld:pubmed
pubmed-article:18359663	pubmed:citationSubset	IM	lld:pubmed
pubmed-article:18359663	pubmed:chemical	http://linkedlifedata.com/r...	lld:pubmed
pubmed-article:18359663	pubmed:chemical	http://linkedlifedata.com/r...	lld:pubmed
pubmed-article:18359663	pubmed:chemical	http://linkedlifedata.com/r...	lld:pubmed
pubmed-article:18359663	pubmed:chemical	http://linkedlifedata.com/r...	lld:pubmed
pubmed-article:18359663	pubmed:chemical	http://linkedlifedata.com/r...	lld:pubmed
pubmed-article:18359663	pubmed:chemical	http://linkedlifedata.com/r...	lld:pubmed
pubmed-article:18359663	pubmed:chemical	http://linkedlifedata.com/r...	lld:pubmed
pubmed-article:18359663	pubmed:chemical	http://linkedlifedata.com/r...	lld:pubmed
pubmed-article:18359663	pubmed:chemical	http://linkedlifedata.com/r...	lld:pubmed
pubmed-article:18359663	pubmed:status	MEDLINE	lld:pubmed
pubmed-article:18359663	pubmed:month	Jun	lld:pubmed
pubmed-article:18359663	pubmed:issn	1386-6532	lld:pubmed
pubmed-article:18359663	pubmed:author	pubmed-author:HaagmansB LBL	lld:pubmed
pubmed-article:18359663	pubmed:author	pubmed-author:HanselB CBC	lld:pubmed
pubmed-article:18359663	pubmed:author	pubmed-author:BigotGG	lld:pubmed
pubmed-article:18359663	pubmed:author	pubmed-author:JanssenH L...	lld:pubmed
pubmed-article:18359663	pubmed:author	pubmed-author:ter BorgM JMJ	lld:pubmed
pubmed-article:18359663	pubmed:issnType	Print	lld:pubmed
pubmed-article:18359663	pubmed:volume	42	lld:pubmed
pubmed-article:18359663	pubmed:owner	NLM	lld:pubmed
pubmed-article:18359663	pubmed:authorsComplete	Y	lld:pubmed
pubmed-article:18359663	pubmed:pagination	160-4	lld:pubmed
pubmed-article:18359663	pubmed:dateRevised	2011-11-17	lld:pubmed
pubmed-article:18359663	pubmed:meshHeading	pubmed-meshheading:18359663...	lld:pubmed
pubmed-article:18359663	pubmed:meshHeading	pubmed-meshheading:18359663...	lld:pubmed
pubmed-article:18359663	pubmed:meshHeading	pubmed-meshheading:18359663...	lld:pubmed
pubmed-article:18359663	pubmed:meshHeading	pubmed-meshheading:18359663...	lld:pubmed
pubmed-article:18359663	pubmed:meshHeading	pubmed-meshheading:18359663...	lld:pubmed
pubmed-article:18359663	pubmed:meshHeading	pubmed-meshheading:18359663...	lld:pubmed
pubmed-article:18359663	pubmed:meshHeading	pubmed-meshheading:18359663...	lld:pubmed
pubmed-article:18359663	pubmed:meshHeading	pubmed-meshheading:18359663...	lld:pubmed
pubmed-article:18359663	pubmed:meshHeading	pubmed-meshheading:18359663...	lld:pubmed
pubmed-article:18359663	pubmed:meshHeading	pubmed-meshheading:18359663...	lld:pubmed
pubmed-article:18359663	pubmed:meshHeading	pubmed-meshheading:18359663...	lld:pubmed
pubmed-article:18359663	pubmed:meshHeading	pubmed-meshheading:18359663...	lld:pubmed
pubmed-article:18359663	pubmed:meshHeading	pubmed-meshheading:18359663...	lld:pubmed
pubmed-article:18359663	pubmed:meshHeading	pubmed-meshheading:18359663...	lld:pubmed
pubmed-article:18359663	pubmed:meshHeading	pubmed-meshheading:18359663...	lld:pubmed
pubmed-article:18359663	pubmed:meshHeading	pubmed-meshheading:18359663...	lld:pubmed
pubmed-article:18359663	pubmed:year	2008	lld:pubmed
pubmed-article:18359663	pubmed:articleTitle	ALT and viral load decline during PEG-IFN alpha-2b treatment for HBeAg-positive chronic hepatitis B.	lld:pubmed
pubmed-article:18359663	pubmed:affiliation	Department of Gastroenterology and Hepatology, Erasmus MC, University Medical Centre Rotterdam, Rotterdam, The Netherlands.	lld:pubmed
pubmed-article:18359663	pubmed:publicationType	Journal Article	lld:pubmed